Neurobiology of Aging

Article	Citations
Emerging roles of oxidative stress in brain aging and Alzheimer's disease	205
Multimodality neuroimaging brain-age in UK biobank: relationship to biomedical, lifestyle, and cognitive factors	196
Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain	97
Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer's disease	73
Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer's disease	68
Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease	62
Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer’s disease	55
Identification of expanded repeats in NOTCH2NLC in neurodegenerative dementias	54
Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer's and Parkinson's disease	50
An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene	49
Diffusion MRI biomarkers of white matter microstructure vary nonmonotonically with increasing cerebral amyloid deposition	47
A framework for concepts of reserve and resilience in aging	45
Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease	45
Estimating brain age based on a uniform healthy population with deep learning and structural magnetic resonance imaging	45
Decreased pH in the aging brain and Alzheimer's disease	44
Converging patterns of aging-associated brain volume loss and tissue microstructure differences	43
Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model	43
Volumetric distribution of perivascular space in relation to mild cognitive impairment	42
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features	40
Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease	39
Age-related reduction in motor adaptation: brain structural correlates and the role of explicit memory	39
Rho-kinase ROCK inhibitors reduce oligomeric tau protein	39
Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum	38
Cerebellar dentate nucleus functional connectivity with cerebral cortex in Alzheimer's disease and memory: a seed-based approach	37
Improving brain age prediction models: incorporation of amyloid status in Alzheimer's disease	37

Locus coeruleus MRI contrast is associated with cortical thickness in older adults	35
Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis	35
A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease	35
Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia	34
Normal brain aging and Alzheimer's disease are associated with lower cerebral pH: an in vivo histidine 1H-MR spectroscopy study	33
Postoperative cognitive dysfunction is made persistent with morphine treatment in aged rats	33
Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice	33
Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project	33
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease	33
Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics	33
Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration	32
Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease	32
Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network	32
Sex differences in risk factors for white matter hyperintensities in non-demented older individuals	32
Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics	31
Comprehensive assessment of PINK1 variants in Parkinson's disease	31
Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease	31
What are the neural correlates of meta-cognition and anosognosia in Alzheimer's disease? A systematic review	31
Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition	31
Do age-related differences in aperiodic neural activity explain differences in resting EEG alpha?	31
Resveratrol-mediated cleavage of amyloid β1–42 peptide: potential relevance to Alzheimer's disease	30
Obesity is associated with reduced cerebral blood flow – modified by physical activity	30
Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta	30
Age-dependent effect of APOE and polygenic component on Alzheimer's disease	30
Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration	29
A quantitative meta-analysis of brain glutamate metabolites in aging	29
Whole-exome sequencing in early-onset Parkinson's disease among ethnic Chinese	29
Linking anatomical and physiological markers of auditory system degeneration with behavioral hearing assessments in a mouse (Mus musculus) model of age-related hearing loss	28
Disappearing metabolic youthfulness in the cognitively impaired female brain	28
Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease	28
Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT-preAD study	28
Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases	28
CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease	28
Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females	28
Excess brain age in the sleep electroencephalogram predicts reduced life expectancy	27
Dysregulated Fc gamma receptor–mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis	27
Influence of structural and functional brain connectivity on age-related differences in fluid cognition	27
GABA levels in ventral visual cortex decline with age and are associated with neural distinctiveness	27
Transient neural network dynamics in cognitive ageing	27
A high-sucrose diet aggravates Alzheimer's disease pathology, attenuates hypothalamic leptin signaling, and impairs food-anticipatory activity in APPswe/PS1dE9 mice	27
MicroRNA predicts cognitive performance in healthy older adults	26
Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial	26
Reduced fractional anisotropy of the genu of the corpus callosum as a cerebrovascular disease marker and predictor of longitudinal cognition in MCI	26
Aging faster: worry and rumination in late life are associated with greater brain age	26
Differential annualized rates of hippocampal subfields atrophy in aging and future Alzheimer's clinical syndrome	26
Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease	25
APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease	24
Visit-to-visit blood pressure variability and regional cerebral perfusion decline in older adults	24
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencepha	24
Causal relationships between gut metabolites and Alzheimer's disease: a bidirectional Mendelian randomization study	24

Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience	24
Sex differences in cognitive aging: a 4-year longitudinal study in marmosets	24
Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults	24
Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets	23
Reduced sialylation triggers homeostatic synapse and neuronal loss in middle-aged mice	23
Association of enlarged perivascular spaces with Aβ and tau deposition in cognitively normal older population	23
Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins	23
Can the interplay between autophagy and apoptosis be targeted as a novel therapy for Parkinson's disease?	23
Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease	22
Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome	22
Sleep/wake cycle alterations as a cause of neurodegenerative diseases: A Mendelian randomization study	22
Fear acquisition and extinction deficits in amnestic mild cognitive impairment and early Alzheimer's disease	22
Patterns of olfactory functional networks in Parkinson's disease dementia and Alzheimer's dementia	22
APOE region molecular signatures of Alzheimer's disease across races/ethnicities	22
Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease	22
Cognitive and neuroimaging profiles of older adults with dual decline in memory and gait speed	22
Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β–negative cognitively normal individuals	22
Abnormal tau in amyloid PET negative individuals	21
Extreme downregulation of chromosome Y and Alzheimer's disease in men	21
White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia	21
Early-stage dysfunction of hippocampal theta and gamma oscillations and its modulation of neural network in a transgenic 5xFAD mouse model	21
Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice	21
Reelin in the Years: decline in the number of reelin immunoreactive neurons in layer II of the entorhinal cortex in aged monkeys with memory impairment	21
SQSTM1/p62 variants in 486 patients with familial ALS from Germany and Sweden	21
A novel role for SHARPIN in amyloid-β phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer's disease	20
Multivariate analysis reveals anatomical correlates of naming errors in primary progressive aphasia	20
Different patterns of functional network reorganization across the variants of primary progressive aphasia: a graph-theoretic analysis	20
Associations between Alzheimer’s disease polygenic risk scores and hippocampal subfield volumes in 17,161 UK Biobank participants	20
Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers	20
Age- and memory- related differences in hippocampal gray matter integrity are better captured by NODDI compared to single-tensor diffusion imaging	20
Chronic hyperglycemia impairs hippocampal neurogenesis and memory in an Alzheimer’s disease mouse model	19
In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease	19
Cognitive markers of dementia risk in middle-aged women with bilateral salpingo-oophorectomy prior to menopause	19
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease	19
Herpes simplex virus and Alzheimer's disease: a Mendelian randomization study	19
Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease	19
Free-water metrics in medial temporal lobe white matter tract projections relate to longitudinal cognitive decline	19
Complex and regional-specific changes in the morphological complexity of GFAP+ astrocytes in middle-aged mice	18
Microstructural differences in white matter tracts across middle to late adulthood: a diffusion MRI study on 7167 UK Biobank participants	18
Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals	18
Alzheimer amyloid-β- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood	18
Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease	18
Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies	18
Increased functional connectivity supports language performance in healthy aging despite gray matter loss	18
The relationship between DNA methylation in neurotrophic genes and age as evidenced from three independent cohorts: differences by delirium status	18
Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model	18
Mitonuclear interactions influence Alzheimer's disease risk	18
Cystatin C, cognition, and brain MRI findings in 90+-year-olds	18
Functional connectivity between the entorhinal and posterior cingulate cortices underpins navigation discrepancies in at-risk Alzheimer's disease	18
A machine learning approach to screen for preclinical Alzheimer's disease	18
Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum	18
The age-related microglial transformation in Alzheimer's disease pathogenesis	18
Exercise interventions do not impact brain volume change in older adults: a systematic review and meta-analysis	17
TFEB protein expression is reduced in aged brains and its overexpression mitigates senescence-associated biomarkers and memory deficits in mice	17
Unlocking the causal link of metabolically different adiposity subtypes with brain volumes and the risks of dementia and stroke: A Mendelian randomization study	17
Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology	17
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers	17
Distinct phosphorylation profiles of tau in brains of patients with different tauopathies	17
Consequences of hyperphosphorylated tau on the morphology and excitability of hippocampal neurons in aged tau transgenic mice	17
Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology	17
Evidence of sex differences in cellular senescence	17
Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?	17
Age-related neuroinflammation and pathology in the locus coeruleus and hippocampus: beta-adrenergic antagonists exacerbate impairment of learning and memory in aged mice	17
Loss of NRF2 accelerates cognitive decline, exacerbates mitochondrial dysfunction, and is required for the cognitive enhancing effects of Centella asiatica during aging	17
The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease	17
Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer's disease: a 24-month follow-up study	16
Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome	16
Brain-predicted age difference is associated with cognitive processing in later-life	16
Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis	16
Brain activity during walking in older adults: Implications for compensatory versus dysfunctional accounts	16
Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy	16
Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients	16
Dose‐dependent relationship between social drinking and brain aging	16
Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults	16
Age-related dedifferentiation and hyperdifferentiation of perceptual and mnemonic representations	16
Genetic risk of dementia modifies obesity effects on white matter myelin in cognitively healthy adults	16
Characterizing the protracted neurobiological and neuroanatomical effects of paraquat in a murine model of Parkinson's disease	15
Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts	15
Reduced firing rates of pyramidal cells in the frontal cortex of APP/PS1 can be restored by acute treatment with levetiracetam	15
Improving brain age estimates with deep learning leads to identification of novel genetic factors associated with brain aging	15

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease	15
Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson's disease	15
Brain network modulation in Alzheimer's and frontotemporal dementia with transcranial electrical stimulation	15
In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy	15
Hippocampal shape across the healthy lifespan and its relationship with cognition	15
Age- and gender-related differences in brain tissue microstructure revealed by multi-component T2 relaxometry	15
Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer’s disease	15
Peripheral visual perception during natural overground dual-task walking in older and younger adults	15
Tau in the brain interstitial fluid is fragmented and seeding–competent	15
Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk	15
Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts	15
Significance of inhibitory recruitment in aging with preserved cognition: limiting gamma-aminobutyric acid type A α5 function produces memory impairment	15
Does amnesia specifically predict Alzheimer’s pathology? A neuropathological study	15
Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition	15
Evaluation of early microstructural changes in the R6/1 mouse model of Huntington's disease by ultra-high field diffusion MR imaging	15
The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals	15
Education and age-related differences in cortical thickness and volume across the lifespan	15
In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies	15
Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-ε4 carriers	15
Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns	15
Enriching activities during childhood are associated with variations in functional connectivity patterns later in life	15
Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease	15
Voluntary exercise increases brain tissue oxygenation and spatially homogenizes oxygen delivery in a mouse model of Alzheimer's disease	15
Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories	15
A neural signature of regularity in sound is reduced in older adults	15
Female mice are resilient to age-related decline of substantia nigra dopamine neuron firing parameters	15
Orthogonal moment diffusion tensor decomposition reveals age-related degeneration patterns in complex fiber architecture	14
Age-related differences in cerebral blood flow and cortical thickness with an application to age prediction	14
Functional connectivity differences in Alzheimer's disease and amnestic mild cognitive impairment associated with AT(N) classification and anosognosia	14
Quality of sleep predicts increased frontoparietal network connectivity in patients with mild cognitive impairment	14
PLA2G6 variants associated with the number of affected alleles in Parkinson’s disease in Japan	14
Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease	14
Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson’s disease, mild cognitive impairment, Alzheimer’s disease, and elderly healthy control	14
Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study	14
Frontostriatal functional connectivity supports reward-enhanced memory in older adults	14
Repression of eEF2 kinase improves deficits in novel object recognition memory in aged mice	14
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis	14
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer’s disease	14
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias	14
Initial motor reserve and long-term prognosis in Parkinson's disease	14
LTP-like plasticity is impaired in amyloid-positive amnestic MCI but independent of PET-amyloid burden	14
Association between telomere length and Parkinson's disease: a Mendelian randomization study	14
Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education	14
Multimodal in vivo and postmortem assessments of tau in Lewy body disorders	14
Brain tissue properties link cardio-vascular risk factors, mood and cognitive performance in the CoLaus|PsyCoLaus epidemiological cohort	14
Stabilization of microtubules improves cognitive functions and axonal transport of mitochondria in Alzheimer's disease model mice	14
Long-term maintenance of multitasking abilities following video game training in older adults	14
Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: a two-decade analysis	14
The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1	14
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation	14
Molecular imaging of beta-amyloid deposition in late-life depression	14
Imaging tau burden in dementia with Lewy bodies using [18F]-AV1451 positron emission tomography	14
Mendelian randomization integrating GWAS and mQTL data identified novel pleiotropic DNA methylation loci for neuropathology of Alzheimer’s disease	14
Global brain volume and N-acetyl-aspartate decline over seven decades of normal aging	14
Propagation patterns in motor neuron diseases: Individual and phenotype-associated disease-burden trajectories across the UMN-LMN spectrum of MNDs	13
The effect of aging, Parkinson's disease, and exogenous dopamine on the neural response associated with auditory regularity processing	13
Right hippocampal volume mediation of subjective memory complaints differs by hypertension status in healthy aging	13
Psychosis-associated DNA methylomic variation in Alzheimer's disease cortex	13
C-reactive protein and risk of Alzheimer's disease	13
Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's disease	13
Amyloid-β positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume	13
Gray matter volume in the right angular gyrus is associated with differential patterns of multisensory integration with aging	13
Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain	13
Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer’s disease: a case-control study	13
Gray matter changes related to microglial activation in Alzheimer's disease	13
Mutation spectrum of amyotrophic lateral sclerosis in Central South China	13
Lateral entorhinal cortex dysfunction in amnestic mild cognitive impairment	13
Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice	13
Generalization of memory-related brain function in asymptomatic older women with a family history of late onset Alzheimer's Disease: Results from the PREVENT-AD Cohort	13
Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer’s disease	13
Impact of modifiable risk factors on Alzheimer's disease: A two-sample Mendelian randomization study	13
Effects of exercise training on neuromuscular junctions and their active zones in young and aged muscles	13
Reconfiguration and dedifferentiation of functional networks during cognitive control across the adult lifespan	13
Positivity effect in aging: evidence for the primacy of positive responses to emotional ambiguity	13
Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia	12
The geriatric pain experience in mice: intact cutaneous thresholds but altered responses to tonic and chronic pain	12
Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's disease	12
C9orf72 hexanucleotide repeat expansion in Indian patients with ALS: a common founder and its geographical predilection	12
Impact of BDNF and sex on maintaining intact memory function in early midlife	12
Do menopausal status and APOE4 genotype alter the long-term effects of intensive lifestyle intervention on cognitive function in women with type 2 diabetes mellitus?	12
Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature	12
Cognitive network hyperactivation and motor cortex decline correlate with ALS prognosis	12
The association between inadequate sleep and accelerated brain ageing	12
Metabolic syndrome and its components in relation to in vivo brain amyloid and neurodegeneration in late middle age	12
Associations of increased interstitial fluid with vascular and neurodegenerative abnormalities in a memory clinic sample	12
Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study	12
Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging	12
Multimodal hippocampal and amygdala subfield volumetry in polygenic risk for Alzheimer's disease	12
Progression of neuroimaging markers of cerebral small vessel disease in older adults: A 6-year follow-up study	12
Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study	12
Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson's disease mice	12
Age-related differences in resting-state and task-based network characteristics and cognition: a lifespan sample	12
Pain processing in older adults with dementia-related cognitive impairment is associated with frontal neurodegeneration	12
Genotype-phenotype correlation of Parkinson's disease with PRKN variants	12
Microvascular degeneration occurs before plaque onset and progresses with age in 3xTg AD mice	11